Utility of Fluorescence and Photoacoustic Imaging Intraoperatively to Assist With Robotic Assisted Minimally Invasive Surgery
I. The primary objective of this pilot study is to assess the ability of fluorescent imaging
and photoacoustic imaging (PAI) in a clinical setting to distinguish benign from malignant
I. To qualitatively determine the possible benefit of PAI and fluorescent imaging over
traditional white light imaging.
Patients undergo fluorescence imaging and PAI during robot assisted laparoscopic surgery.
Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic
Margin/lesion status determined by histopathology (cancer status [positive vs negative] as well as grade [Gleason grade 1-5 for prostate cancer, high vs low grade for bladder cancer, and Fuhrman grade 1-4 for kidney cancer])
The average lesion signal intensity on PAI and fluorescent imaging will be tested against the histology at pathological examination of the tissue sample.
Up to 6 months after surgery
United States: Institutional Review Board
|Stanford University||Stanford, California 94305|